Botox Related Published Studies
Well-designed clinical trials related to Botox (Botulinum Toxin Type A)
Effect of Botulinum Toxin Injection on Nocturnal Bruxism: A Randomized Controlled Trial. [2009.09.26]
Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantarflexor: a randomized controlled trial. [2009.09]
A preliminary assessment of the benefits of the addition of botulinum toxin a to a conventional therapy program on the function of people with longstanding stroke. [2009.09]
A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy. [2009.09]
Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. [2009.09]
Botulinum a toxin/dimethyl sulfoxide bladder instillations for women with refractory idiopathic detrusor overactivity: a phase 1/2 study. [2009.08]
Botulinum toxin type A injection in alleviating postoperative pain and improving quality of life in lower extremity limb lengthening and deformity correction: a pilot study. [2009.07]
An open-label, randomized, 64-week study repeating 10- and 20-U doses of botulinum toxin type A for treatment of glabellar lines in Japanese subjects. [2009.07]
Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy. [2009.06]
Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes. [2009.06]
A single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: safety and efficacy. [2009.06]
Blind multicenter study of the efficacy and safety of injections of a commercial preparation of botulinum toxin type A reconstituted up to 15 days before injection. [2009.06]
Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial. [2009.06]
Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder. [2009.06]
Clinical trial: effects of botulinum toxin on Levator ani syndrome--a double-blind, placebo-controlled study. [2009.05.01]
The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment. [2009.05]
Reduction of pain and anxiety prior to botulinum toxin injections with a new topical anesthetic method. [2009.05]
Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial. [2009.05]
Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report. [2009.05]
Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study. [2009.05]
Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. [2009.04.28]
Sympathetic block with botulinum toxin to treat complex regional pain syndrome. [2009.03]
High versus low concentration botulinum toxin A for benign essential blepharospasm: does dilution make a difference? [2009.03]
A four-month randomized, double-blind evaluation of the efficacy of botulinum toxin type A for the treatment of glabellar lines in women with skin types V and VI. [2009.03]
Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial. [2009.03]
Comparative study between botulinum toxin injection and partial division of puborectalis for treating anismus. [2009.03]
Dynamic splinting after treatment with botulinum toxin type-A: A randomized controlled pilot study. [2009.02.04]
Dynamic splinting after treatment with botulinum toxin type-A: A randomized controlled pilot study. [2009.02]
Botulinum toxin: could it be an effective treatment for chronic tension-type headache? [2009.02]
Respective potencies of Botox and Dysport in a human skin model: a randomized, double-blind study. [2009.01.30]
Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study. [2009.01]
Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes. [2009.01]
Subcutaneous histamine versus botulinum toxin type A in migraine prophylaxis: a randomized, double-blind study. [2009.01]
Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin. [2009.01]
Comparative study between biofeedback retraining and botulinum neurotoxin in the treatment of anismus patients. [2009.01]
Therapeutic effects of add-on botulinum toxin A on patients with large benign prostatic hyperplasia and unsatisfactory response to combined medical therapy. [2009]
Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units. [2009]
The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A. [2008.12]
Biological activity of two botulinum toxin type A complexes (Dysport and Botox) in volunteers: a double-blind, randomized, dose-ranging study. [2008.12]
Effectiveness of sedation using nitrous oxide compared with enteral midazolam for botulinum toxin A injections in children. [2008.11]
Randomized clinical trial of botulinum toxin injection for pain relief in patients with thrombosed external haemorrhoids. [2008.11]
A single-blinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot. [2008.11]
The effects of one botulinum toxin type A (BTX-A) injection after UPPP. [2008.10]
A comparison of the effects of botulinum toxin A and steroid injection on nasal allergy. [2008.09]
A double-blind, randomized, placebo-controlled, two-dose comparative study of botulinum toxin type A for treating glabellar lines in Japanese subjects. [2008.09]
Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. [2008.09]
Upper limb corticomotor projections and physiological changes that occur with botulinum toxin-A therapy in children with hemiplegic cerebral palsy. [2008.08]
Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. [2008.08]
The effect of botulinum toxin type A on full-face intense pulsed light treatment: a randomized, double-blind, split-face study. [2008.08]
Effects of intramural administration of Botulinum Toxin A on gastric emptying and eating capacity in obese patients. [2008.08]
A Double-Blind, Randomized, Placebo-Controlled, Two-Dose Comparative Study of Botulinum Toxin Type A for Treating Glabellar Lines in Japanese Subjects. [2008.07.29]
Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy. [2008.07.08]
Questioning the Need to Use Botox Within 4 Hours of Reconstitution: A Study of Fresh vs 2-Week-Old Botox. [2008.07]
Efficacy and safety of purified botulinum toxin type A (Dysport((R))) for the treatment of benign essential blepharospasm: A randomized, placebo-controlled, phase II trial. [2008.07]
Effect of upper limb botulinum toxin-A therapy on health-related quality of life in children with hemiplegic cerebral palsy. [2008.07]
Refractory idiopathic urge urinary incontinence and botulinum A injection. [2008.07]
Botulinum toxin type a as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. [2008.06]
Can we identify predictors of multilevel botulinum toxin A injections in children with cerebral palsy who walk with a flexed knee pattern? [2008.06]
A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder. [2008.06]
Botulinum toxin injection with and without electromyographic assistance for treatment of abducens nerve palsy: a pilot study. [2008.06]
Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia. [2008.05]
Botulinum toxin type A injections into the calf muscles for treatment of spastic equinus in cerebral palsy: a randomized trial comparing single and multiple injection sites. [2008.05]
Shoulder pain and external rotation in spastic hemiplegia do not improve by injection of botulinum toxin A into the subscapular muscle. [2008.05]
[Botulinum toxin A (BTX-A) point injection for treatment of the third lumbar transverse process syndrome] [2008.05]
A dose-response relationship research on botulinum toxin type A local intramuscular injections of lower extremity spasticity in children with cerebral palsy. [2008.05]
Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. [2008.04]
EMLA Cream Application Without Occlusive Dressing Before Upper Facial Botulinum Toxin Injection: A Randomized, Double-Blind, Placebo-Controlled Trial. [2008.04]
Combined effects of botulinum toxin and casting treatments on lower limb spasticity after stroke. [2008.04]
Botulinum toxin type B vs. type A in toxin-naive patients with cervical dystonia: Randomized, double-blind, noninferiority trial. [2008.03.15]
Efficacy and safety of purified botulinum toxin type A (Dysport((R))) for the treatment of benign essential blepharospasm: A randomized, placebo-controlled, phase II trial. [2008.03.04]
Pericranial injection of botulinum toxin type A (Dysport) for tension-type headache - a multicentre, double-blind, randomized, placebo-controlled study. [2008.03]
Different formulations of botulinum toxin type A have different migration characteristics: a double-blind, randomized study. [2008.03]
Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia. [2008.03]
Botulinum toxin type a versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis. [2008.03]
Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders. [2008.02]
Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse. [2008.02]
Botulinum toxin A for the treatment of delayed gastric emptying. [2008.02]
Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine. [2008.02]
Comparative electrophysiological study of response to botulinum toxin type B in Japanese and Caucasians. [2008.01.30]
Intramuscular botulinum toxin-A reduces hemiplegic shoulder pain: a randomized, double-blind, comparative study versus intraarticular triamcinolone acetonide. [2008.01]
Botox: shaken, not stirred. [2008.01]
The analgesic effect of botulinum-toxin A on postwhiplash neck pain. [2008.01]
Associated reactions after stroke: a randomized controlled trial of the effect of botulinum toxin type A. [2008.01]
Does botulinum toxin a combined with bracing prevent hip displacement in children with cerebral palsy and "hips at risk"? A randomized, controlled trial. [2008.01]
Therapeutic use of botulinum toxin type a in treating neck and upper-back pain of myofascial origin: a pilot study. [2008.01]
A randomized pilot study comparing the action halos of two commercial preparations of botulinum toxin type A. [2008.01]
Bupivacaine-induced myotoxicity and its effect on botulinum toxin paresis. [2008.01]
Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial. [2008]
Equipotent concentrations of Botox and Dysport in the treatment of palmar hyperhidrosis. [2008]
Cooling by frozen gel pack as pain relief during treatment of axillary hyperhidrosis with botulinum toxin a injections. [2008]
A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus. [2007.12]
Botulinum-A toxin: solo treatment for neuropathic noncompliant bladder. [2007.12]
Botulinum Toxin Type A as Migraine Preventive Treatment in Patients Previously Failing Oral Prophylactic Treatment Due To Compliance Issues. [2007.11.28]
Botulinum Toxin Type A in the Treatment of Chronic Migraine Without Medication Overuse. [2007.11.27]
Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. [2007.11.01]
Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy. [2007.11]
Clinical efficacy of botulinum toxin type A reconstituted and refrigerated 1 week before its application in external canthus dynamic lines. [2007.11]
Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids. [2007.11]
Sensory integration in writer's cramp: comparison with controls and evaluation of botulinum toxin effect. [2007.10]
Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity. [2007.10]
Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. [2007.10]
|
